National Bank of Canada
OCDX

National Bank of Canada’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

National Bank of Canada’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$2K – 3102
2022
Q1 		$2K Hold
100
– – ﹤0.01% 2750
2021
Q4 		$2K Buy
+100
New +$1.97K ﹤0.01% 2717

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

National Bank of Canada's OCDX Position: Q2 2022 in Review

National Bank of Canada sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 100 shares — an estimated $2K sold.

National Bank of Canada first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • National Bank of Canada reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • National Bank of Canada sold 100 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $2K.
  • National Bank of Canada first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
  • National Bank of Canada's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $2K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on National Bank of Canada's 13F filing for Q2 2022, filed 28 Jul 2022.